122 related articles for article (PubMed ID: 10374866)
1. Unusual clinical presentation in a patient with myelodysplastic syndrome, with subsequent hematological remission and suppression of the malignant clone following treatment with cyclosporine A, erythropoietin and granulocyte colony-stimulating factor.
Samuelsson J; Lärfars G
Leuk Res; 1999 May; 23(5):513-7. PubMed ID: 10374866
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin, with and without granulocyte-colony stimulating factor (G-CSF), in the treatment of myelodysplastic syndrome (MDS) patients.
Miller K
Leuk Res; 1998 May; 22 Suppl 1():S13-6. PubMed ID: 9734694
[No Abstract] [Full Text] [Related]
3. Failure of combination therapy with recombinant granulocyte colony-stimulating factor and erythropoietin in myelodysplastic syndromes.
Imamura M; Kobayashi M; Kobayashi S; Yoshida K; Mikuni C; Ishikawa Y; Matsumoto S; Sakamaki S; Niitsu Y; Hinoda Y
Ann Hematol; 1994 Apr; 68(4):163-6. PubMed ID: 7516190
[TBL] [Abstract][Full Text] [Related]
4. A hematological remission by clonal hematopoiesis after treatment with recombinant human granulocyte-macrophage colony-stimulating factor and erythropoietin in a patient with therapy-related myelodysplastic syndrome.
Bessho M; Itoh Y; Kataumi S; Kawai N; Matsuda A; Jinnai I; Saitoh M; Hirashima K; Minamihisamatsu M
Leuk Res; 1992; 16(2):123-31. PubMed ID: 1545564
[TBL] [Abstract][Full Text] [Related]
5. Bullous pyoderma gangrenosum in a patient with myelodysplastic syndrome during granulocyte colony-stimulating factor therapy.
Lewerin C; Mobacken H; Nilsson-Ehle H; Swolin B
Leuk Lymphoma; 1997 Aug; 26(5-6):629-32. PubMed ID: 9389372
[TBL] [Abstract][Full Text] [Related]
6. Sustained trilineage recovery and disappearance of abnormal chromosome clone in a patient with myelodysplastic syndrome following combination therapy with cytokines (granulocyte colony-stimulating factor and erythropoietin) and high-dose methylprednisolone.
Imai Y; Fukuoka T; Nakatani A; Ohsaka A; Takahashi A
Br J Haematol; 1996 Apr; 93(1):146-50. PubMed ID: 8611449
[TBL] [Abstract][Full Text] [Related]
7. Trilineage response to granulocyte colony-stimulating factor administration in a patient with myelodysplastic syndrome.
Perugini O; Montanari G; Nalli G
Haematologica; 1995; 80(3):234-7. PubMed ID: 7545637
[TBL] [Abstract][Full Text] [Related]
8. Treatment of myelodysplastic syndromes with hematopoietic growth factors.
Ganser A; Hoelzer D
Hematol Oncol Clin North Am; 1992 Jun; 6(3):633-53. PubMed ID: 1377194
[TBL] [Abstract][Full Text] [Related]
9. [Effect of recombinant human G-CSF combined with EPO in treatment of patients with MDS].
Li ZY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):512-3. PubMed ID: 15972155
[TBL] [Abstract][Full Text] [Related]
10. Combined use of erythropoietin and G-CSF in the treatment of myelodysplastic syndromes.
Haematologica; 1999 Dec; 84(12):1057. PubMed ID: 10586204
[No Abstract] [Full Text] [Related]
11. A strategy for erythropoietin treatment in myelodysplastic syndromes.
Hast R
Med Oncol; 1999 Sep; 16(3):188-90. PubMed ID: 10523798
[No Abstract] [Full Text] [Related]
12. Treatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony-stimulating factor and erythropoietin.
Mantovani L; Lentini G; Hentschel B; Wickramanayake PD; Loeffler M; Diehl V; Tesch H
Br J Haematol; 2000 May; 109(2):367-75. PubMed ID: 10848827
[TBL] [Abstract][Full Text] [Related]
13. Revisiting use of growth factors in myelodysplastic syndromes.
Newman K; Maness-Harris L; El-Hemaidi I; Akhtari M
Asian Pac J Cancer Prev; 2012; 13(4):1081-91. PubMed ID: 22799286
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte colony-stimulating factor and erythropoietin for the anemia of myelodysplastic syndromes: a real improvement with respect to erythropoietin alone?
Musto P; Falcone A; Carotenuto M; Catalano L; Cennamo A; Rotoli B
Blood; 1994 Sep; 84(5):1687-8. PubMed ID: 7520783
[No Abstract] [Full Text] [Related]
15. Haematological improvement by long-term administration of recombinant human granulocyte-colony stimulating factor and recombinant human erythropoietin in a patient with severe aplastic anaemia.
Nawata J; Toyoda Y; Nisihira H; Honda K; Kigasawa H; Nagao T
Eur J Pediatr; 1994 May; 153(5):325-7. PubMed ID: 7518392
[TBL] [Abstract][Full Text] [Related]
16. Revisiting the use of recombinant erythropoietin in myelodysplastic syndromes.
Musto P
Clin Lymphoma; 2005 Jun; 6(1):52-5. PubMed ID: 15989709
[No Abstract] [Full Text] [Related]
17. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.
Balleari E; Rossi E; Clavio M; Congiu A; Gobbi M; Grosso M; Secondo V; Spriano M; Timitilli S; Ghio R
Ann Hematol; 2006 Mar; 85(3):174-80. PubMed ID: 16408206
[TBL] [Abstract][Full Text] [Related]
18. Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor.
Estey E; Thall P; Andreeff M; Beran M; Kantarjian H; O'Brien S; Escudier S; Robertson LE; Koller C; Kornblau S
J Clin Oncol; 1994 Apr; 12(4):671-8. PubMed ID: 7512125
[TBL] [Abstract][Full Text] [Related]
19. Effect of low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor priming regimen on patients with advanced myelodysplastic syndrome or acute myeloid leukemia transformed from myelodysplastic syndrome.
Wu L; Li X; Su J; Chang C; He Q; Zhang X; Xu L; Song L; Pu Q
Leuk Lymphoma; 2009 Sep; 50(9):1461-7. PubMed ID: 19672772
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic spectrum in the treatment of myelodysplastic syndromes.
Hofmann WK; Baldus C; Uharek L; Thiel E
Expert Opin Pharmacother; 2004 Dec; 5(12):2451-8. PubMed ID: 15571463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
